Realbotix Reports Financial Results for Q2-2026

• Q2-2026 Financial Results: Reported revenue of $225,000 for the quarter ended March 31, 2026, a significant decline from $727,000 in the prior year period. Year-to-date (YTD) revenue is $578,000 versus $1,543,000 previously.
• Profitability: Reported a comprehensive income profit of $442,375 for Q2 and a net loss of $(849,000) for YTD. The quarterly profit was driven by one-time gains from debt repayment and the sale of intangible assets (Tokens.com domain), not operational earnings.
• Strategic Transaction: Confirmed progress on the reverse takeover with Onconetix, Inc. (NASDAQ: ONCO). Expected to close before October 31, 2026. Realbotix Corp. will retain a 75–90% ownership stake in the Nasdaq-listed entity.
• Operational Updates: Expanded robotics/AI engineering team from 8 to 20 full-time equivalents. Completed product deliveries to a large telecommunications client (Ericsson) in April, though revenue recognition is pending delivery policy.
• Cost Structure: Operating expenses increased to $1,746,000 for Q2 ($3,423,000 YTD) due to scaling hiring for robotics and AI product lines. Gross margins were negative (-1.7%) in Q2 due to one-time accounting adjustments but positive (19.0%) for six months.

• Revenue Decline: The 69% year-over-year revenue drop is a concerning operational signal, indicating the pivot from crypto-staking to humanoid robotics has not yet translated into scaled commercial sales. This contradicts the growth narrative often associated with such pivots.
• One-Time Gains Masking Losses: While Q2 showed a profit, it was entirely due to non-recurring asset sales (Tokens.com domain). The core business remains loss-making ($849k YTD loss), which is standard for pre-revenue tech but requires careful monitoring of burn rate.
• RTO Progression: The confirmation that the Nasdaq listing transaction is proceeding towards a Q3/Q4 2026 closing was previously announced in February and May 19, 2026. This news confirms execution rather than introducing new material upside.
• Cash Position: The company remains debt-free with approximately $8.6M cash (including receivables from domain sales), providing over 12 months of runway at the current burn rate of ~$425k/month. This mitigates immediate solvency risk.
• Overall Impact: The news is largely consistent with previous expectations regarding the RTO timeline and financial health. The revenue miss is negative but offset by strong liquidity management. It does not fundamentally alter the investment thesis but highlights execution risks in commercialization.

• Core Business: Realbotix Corp. is pivoting from crypto-staking operations to AI-integrated humanoid robotics.
• Flagship Project: The company focuses on "Aria" and other humanoid robots equipped with proprietary AI vision systems (Vinci) for enterprise applications in healthcare, education, hospitality, and customer engagement.
• Technology: Patented human interface layer allowing autonomous behavior without teleoperation, eye-tracking, emotional signal capture, and multilingual conversational AI.
• Strategic Pivot: Elimination of crypto-staking to allocate resources entirely to the robotics division, aiming for institutional and enterprise demand rather than direct-to-consumer sales.